Dr. Laura A. Campbell
Claim this profileKaiser Permanente-Oakland
Expert in Tumors
Expert in Brain Tumor
56 reported clinical trials
105 drugs studied
About Laura A. Campbell
Education:
- Obtained MD from the University of California, San Francisco (UCSF) in 2015.
- Completed residency in Internal Medicine at Kaiser Permanente Oakland Medical Center in 2018.
- Board Certified in Internal Medicine by the American Board of Internal Medicine.
Experience:
- Practicing as an internal medicine physician at Kaiser Permanente-Oakland since 2018.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Kaiser Permanente-Oakland
Kaiser Permanente Oakland M.C.
Clinical Trials Laura A. Campbell is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Laura A. Campbell
Clinical Trial Related7 years of experience running clinical trials · Led 56 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Laura A. Campbell has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Laboratory Biomarker Analysis
- Carboplatin
- Doxorubicin Hydrochloride
Breakdown of trials Laura A. Campbell has run
Tumors
Brain Tumor
Neuroblastoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Laura A. Campbell specialize in?
Laura A. Campbell focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Laura A. Campbell currently recruiting for clinical trials?
Yes, Laura A. Campbell is currently recruiting for 13 clinical trials in Oakland California. If you're interested in participating, you should apply.
Are there any treatments that Laura A. Campbell has studied deeply?
Yes, Laura A. Campbell has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Laura A. Campbell?
Apply for one of the trials that Laura A. Campbell is conducting.
What is the office address of Laura A. Campbell?
The office of Laura A. Campbell is located at: Kaiser Permanente-Oakland, Oakland, California 94611 United States. This is the address for their practice at the Kaiser Permanente-Oakland.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.